Pavunalimab Human Monoclonal Antibody
Pavunalimabis a research-grade recombinant antibody targeting CD223. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4
UniProt
P18627, P16410
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
Half-IGG1-kappa/ (scFv-heavy-kappa) -h-CH2-CH3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K7464902 1.0 µg DNA
Tmed9 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details PMIRH610PA-1 Bacterial Streak
Human pre-microRNA Expression Construct Lenti-miR-610
Sign In for Pricing
View Details